Search

Learn about the work of Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2019 Chairman’s Prize.

… Monday, August 19, 2019 Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2019 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Louis V. Gerstner,

“Plum” from the Caring Canines program will compete June 11-13.

… Wednesday, June 9, 2021 “Plum,” a therapy dog in the MSK Caring Canines program, is competing in the 2021 Westminster Kennel Club Dog Show on June 11-13. Plum, who is a black Flat-Coated Retriever, is owned by MaryJane Koren, a retired geriatric doctor who has been a volunteer in the Caring Canines program

During his State of the Union address, President Obama proposed a “moonshot” to cure cancer. Following that, MSK physicians attended a roundtable discussion at the World Economic Forum in Davos-Klosters, Switzerland to discuss progress on what a cure might look like.

… Thursday, January 14, 2016 Embed from Getty Images Summary President Obama’s proposal during the State of the Union address for a “moonshot” to cure cancer reflects the ambitious goal of scientists and government officials to conquer the disease. MSK researchers maintain that, while a cure is unlikely

Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.

… Wednesday, July 1, 2009 Summary Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist. Jennifer A. Zallen , a member of the Developmental Biology Program in the Sloan

Learn how a patient’s intestinal bacteria may influence the risk of cancers such as leukemia or lymphoma returning after bone marrow transplantation.

… Friday, March 17, 2017 Summary Researchers have known that intestinal bacteria, known as gut microbiota, can affect the risk of complications from bone marrow transplantation such as graft versus host disease. A new MSK study found an association between the presence of a bacterial group and a lower

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

… Thursday, May 9, 2013 Summary Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years. Christopher D. Lima , a structural biologist at Memorial Sloan Kettering,

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.

… Thursday, July 29, 2021 Mesothelioma is a rare cancer that affects the lining surrounding organs, usually in the chest and abdomen. Treating this disease has been challenging because in most cases it is not possible to remove all the cancer with surgery. The FDA has approved only two new therapies since

When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.

… Saturday, July 1, 2023 By Matt Tontonoz When Urvi Shah, MD , was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat. She thought, as a doctor who was training

MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.

… Tuesday, August 8, 2017 Summary Most non-anaplastic thyroid cancers grow slowly and do not pose a threat. However, a small percentage become aggressive and spread quickly. Researchers have identified mutations that appear to turn these nonthreatening thyroid tumors into aggressive cancers. Highlights

Dr. Blinderman is a national leader in supportive care.

… Wednesday, November 1, 2023 Craig D. Blinderman, MD has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Blinderman is a national leader in supportive care who comes to MSK from Columbia University Medical Center/NewYork-Presbyterian Hospital, where